Product Information
ADALIMUMAB-AACF(CF) PEN 40 MG/0.8 ML (2 PACK) is a generic product labeled by Fresenius Kabi USA, LLC, priced at $873.7122 per EA under NDC 65219061299. Its NADAC has been published 54 times since Jun 18, 2025.
Manufacturer
Fresenius Kabi USA, LLCNDC
65219061299
Classification
Generic
Dosage Form
KIT
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Approval Type
Biologic (BLA)
FDA Application
BLA761255On Market Since
12/6/2023
Price Statistics
The NADAC for ADALIMUMAB-AACF(CF) PEN 40 MG/0.8 ML (2 PACK) has been published 54 times since Jun 18, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $873.7122 per EA |
|---|---|
| All-time high | $873.7122 (Jun 24, 2026) |
| All-time low | $871.4500 (Jun 18, 2025) |
| 52-week high | $873.7122 |
| 52-week low | $871.4500 |
| Median price | $872.4906 |
| Average price | $872.5242 |
| Largest weekly change | +0.1% (Sep 17, 2025) |
| Weeks tracked | 54 |
| Tracking since | Jun 18, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the adalimumab market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ADALIMUMAB-AACF(CF) PEN 40 MG/0.8 ML (2 PACK)?
The current National Average Drug Acquisition Cost (NADAC) for ADALIMUMAB-AACF(CF) PEN 40 MG/0.8 ML (2 PACK), manufactured by Fresenius Kabi USA, LLC, is $873.7122 per EA (NDC 65219061299), effective Jun 24, 2026.
How has the price of ADALIMUMAB-AACF(CF) PEN 40 MG/0.8 ML (2 PACK) changed over time?
Over the history we have for it, the NADAC for ADALIMUMAB-AACF(CF) PEN 40 MG/0.8 ML (2 PACK) has held within roughly two percent of its current level. It has been tracked across 54 weekly CMS publications since Jun 18, 2025.
What are the highest and lowest recorded NADAC prices for ADALIMUMAB-AACF(CF) PEN 40 MG/0.8 ML (2 PACK)?
Since Jun 18, 2025, the NADAC for ADALIMUMAB-AACF(CF) PEN 40 MG/0.8 ML (2 PACK) has ranged from a low of $871.4500 (Jun 18, 2025) to a high of $873.7122 (Jun 24, 2026), with a median of $872.4906 per EA.
Are there cheaper alternatives to ADALIMUMAB-AACF(CF) PEN 40 MG/0.8 ML (2 PACK)?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ADALIMUMAB-AACF(CF) PEN 40 MG/0.8 ML (2 PACK), so no direct lower-cost alternative is listed.
Who manufactures ADALIMUMAB-AACF(CF) PEN 40 MG/0.8 ML (2 PACK)?
ADALIMUMAB-AACF(CF) PEN 40 MG/0.8 ML (2 PACK) (NDC 65219061299) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification